The PALIZADE clinical study is evaluating zetomipzomib for the treatment of lupus nephritis, its side effects, and how it affects proteins in the urine. The PALIZADE clinical trial is made up of 3 ...
People with lupus have two categories of risk factors for heart disease. The traditional risk factors that affect the general population apply to people with lupus and appear more frequently among ...